Roopa Industries Limited (BOM:530991)

India · Delayed Price · Currency is INR

48.00

-0.36 (-0.74%)

At close: Aug 18, 2026

-11.11% (1Y)

Market Cap	377.54M -11.1%
Revenue (ttm)	1.26B +1.8%
Net Income	1.28M -93.7%
EPS	0.20 -92.2%
Shares Out	7.87M
PE Ratio	237.32
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	210
Open	48.36
Previous Close	48.36
Day's Range	46.41 - 48.37
52-Week Range	38.10 - 63.40
Beta	-0.06
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Roopa Industries

Roopa Industries Limited manufactures, markets, and sells bulk drugs, intermediaries, and fine chemicals in India and internationally. The company offers triphenyl phosphine, abacavir sulphate, d-penicillamine, s-octabase, DCC, and DPA 3, etc. It also manufactures and exports glucosamine salts. Roopa Industries Limited was incorporated in 1985 and is based in Hyderabad, India. [Read more]

Industry Chemicals and Allied Products

Founded 1985

Employees 51

Stock Exchange Bombay Stock Exchange

Ticker Symbol 530991

Full Company Profile

Financial Performance

In fiscal year 2026, Roopa Industries's revenue was 1.28 billion, an increase of 5.23% compared to the previous year's 1.21 billion. Earnings were 831,000, a decrease of -95.92%.

Financial Statements